Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.29 USD | +1.26% | -0.27% | -47.54% |
Financials (USD)
Sales 2024 * | 441M | Sales 2025 * | 468M | Capitalization | 414M |
---|---|---|---|---|---|
Net income 2024 * | -96M | Net income 2025 * | -81M | EV / Sales 2024 * | 0.66 x |
Net cash position 2024 * | 125M | Net cash position 2025 * | 97.38M | EV / Sales 2025 * | 0.68 x |
P/E ratio 2024 * |
-4.26
x | P/E ratio 2025 * |
-5.14
x | Employees | 1,215 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.01% |
Latest transcript on Nevro Corp.
1 day | +1.26% | ||
1 week | -0.27% | ||
Current month | +6.71% | ||
1 month | -14.53% | ||
3 months | -30.57% | ||
6 months | -29.74% | ||
Current year | -47.54% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Thornal
CEO | Chief Executive Officer | 50 | 23-04-23 |
D. Grossman
CHM | Chairman | 63 | 19-03-18 |
Roderick MacLeod
DFI | Director of Finance/CFO | 57 | 20-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael DeMane
BRD | Director/Board Member | 67 | 11-03-16 |
Karen Prange
BRD | Director/Board Member | 60 | 19-12-16 |
D. Grossman
CHM | Chairman | 63 | 19-03-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 509 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 11.29 | +1.26% | 373,702 |
24-05-02 | 11.15 | +7.11% | 549,412 |
24-05-01 | 10.41 | -1.61% | 2,710,070 |
24-04-30 | 10.58 | -7.36% | 811,532 |
24-04-29 | 11.42 | +0.88% | 367,763 |
Delayed Quote Nyse, May 03, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.54% | 414M | |
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.82B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- NVRO Stock